← FDA Drug Approvals (Drugs@FDA)

NEOSTIGMINE METHYLSULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2022-07-13

Drug application

FDA Application #

ANDA216206

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEOSTIGMINE METHYLSULFATE

Generic name

Neostigmine Methylsulfate

Active ingredients

NEOSTIGMINE METHYLSULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HIKMA

First approval

2022-07-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown